Inactive Instrument

AMAG Pharmaceuticals, Inc.

AMAG

US00163U1060

AMAG Pharmaceuticals, Inc. Announces Resignation of Brian P. Kelley as Board of Directors

September 14, 2017 at 02:50 am IST

On September 12, 2017, Brian P. Kelley notified AMAG Pharmaceuticals, Inc. of his resignation from the board of directors of the company, effective immediately. Mr. resignation is due to competing demands with his new role as a partner at a private equity firm and not the result of any disagreement with the company on any matter relating to the company's operations, policies or practices.

Latest news about AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. Files Submission in Response to the Food and Drug Administration’s Notice of Opportunity for A Hearing and Proposal to Withdraw Approval of Makena® (Hydroxyprogesterone Caproate Injection)	14/20/14	CI
AMAG Pharmaceuticals, Inc. Announces Management Changes	17/20/17	CI
AMAG Pharmaceuticals, Inc. Appoints Michael Porter as Chief Executive Officer	17/20/17	CI
AMAG Pharmaceuticals, Inc. Appoints Ozgur Kilic as Chief Financial Officer	17/20/17	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 1000	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P Composite 1500	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P Global BMI Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 600 Health Care	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P 600	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGS:AMAG) dropped from S&P TMI Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Value Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Value Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Small Cap Completeness Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000 Value Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000 Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Small Cap Comp Value Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2000 Value-Dynamic Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Value-Dynamic Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 2500 Dynamic Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000E Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell 3000E Value Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Microcap Index	13/20/13	CI
AMAG Pharmaceuticals, Inc.(NasdaqGM:AVM) dropped from Russell Microcap Value Index	13/20/13	CI

Chart AMAG Pharmaceuticals, Inc.

Duration

Period

More charts

Company Profile

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+31.74%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.44%	205B
ROCHE HOLDING AG	-5.97%	203B
AMGEN INC.	+6.19%	164B

Other Pharmaceuticals